Titelia

Funds holding ArriVent Biopharma Inc

ISIN US04272N1028 · United States

Fund holders
138
Of which ETFs
30 108 other funds
Value held
204.3M $
Share of capital
17.1 % of 49.3M shares on Aug 10, 2026
FundSharesValueWeight in fundShare of capital
SmallCap Growth Fund I Principal Funds, Inc 2,00462.3K $0.00 %0.00 %as of Apr 30, 2026 ↗
VIP Extended Market Index Portfolio Variable Insurance Products Fund II 1,97245.5K $0.01 %0.00 %as of Mar 31, 2026 ↗
ProShares Ultra Nasdaq Biotechnology ProShares Trust 1,90643.8K $0.05 %0.00 %as of Feb 28, 2026 ↗
Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC 1,90543.9K $0.02 %0.00 %as of Mar 31, 2026 ↗
ProShares Ultra Russell2000 ProShares Trust 1,82742K $0.01 %0.00 %as of Feb 28, 2026 ↗
ProShares UltraPro Russell2000 ProShares Trust 1,82141.8K $0.01 %0.00 %as of Feb 28, 2026 ↗
iShares MSCI World Small-Cap ETF iShares Trust 1,62537.3K $0.00 %0.00 %as of Feb 28, 2026 ↗
SIMT Small Cap Fund SEI INSTITUTIONAL MANAGED TRUST 1,58036.5K $0.01 %0.00 %as of Mar 31, 2026 ↗
ProShares Russell 2000 High Income ETF ProShares Trust 1,27929.4K $0.02 %0.00 %as of Feb 28, 2026 ↗
SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST 1,25128.9K $0.01 %0.00 %as of Mar 31, 2026 ↗
Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS 1,10725.4K $0.00 %0.00 %as of Feb 28, 2026 ↗
EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust 1,01923.5K $0.01 %0.00 %as of Mar 31, 2026 ↗
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST 91221K $0.00 %0.00 %as of Mar 31, 2026 ↗
SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST 91021K $0.02 %0.00 %as of Mar 31, 2026 ↗
Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust 88420.3K $0.01 %0.00 %as of Feb 28, 2026 ↗
TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 87320.1K $0.00 %0.00 %as of Mar 31, 2026 ↗
VIP Total Market Index Portfolio Variable Insurance Products Fund II 76217.6K $0.00 %0.00 %as of Mar 31, 2026 ↗
Total Stock Market Index Trust John Hancock Variable Insurance Trust 74017.1K $0.00 %0.00 %as of Mar 31, 2026 ↗
Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust 71416.4K $0.00 %0.00 %as of Feb 28, 2026 ↗
State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC 68215.7K $0.00 %0.00 %as of Mar 31, 2026 ↗
Penn Series Small Cap Index Fund Penn Series Funds Inc 60013.8K $0.02 %0.00 %as of Mar 31, 2026 ↗
iShares Morningstar Small-Cap ETF iShares Trust 56317.5K $0.01 %0.00 %as of Apr 30, 2026 ↗
Nuveen Life Stock Index Fund TIAA-CREF Life Funds 43710.1K $0.00 %0.00 %as of Mar 31, 2026 ↗
Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds 40512.6K $0.00 %0.00 %as of Apr 30, 2026 ↗
ULTRA SMALL CAP PROFUND ProFunds 36311.3K $0.02 %0.00 %as of Apr 30, 2026 ↗
Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust 3189.9K $0.13 %0.00 %as of Apr 30, 2026 ↗
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 1936K $0.00 %0.00 %as of Apr 30, 2026 ↗
Russell 2000 2x Strategy Fund Rydex Dynamic Funds 1583.6K $0.01 %0.00 %as of Mar 31, 2026 ↗
PROFUND VP ULTRA SMALL CAP ProFunds 1082.5K $0.02 %0.00 %as of Mar 31, 2026 ↗
State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST 1062.4K $0.00 %0.00 %as of Mar 31, 2026 ↗
PROFUND VP SMALL CAP ProFunds 811.9K $0.02 %0.00 %as of Mar 31, 2026 ↗
Russell 2000 Fund Rydex Series Funds 671.5K $0.01 %0.00 %as of Mar 31, 2026 ↗
SMALL-CAP PROFUND ProFunds 591.8K $0.02 %0.00 %as of Apr 30, 2026 ↗
Russell 2000 1.5x Strategy Fund Rydex Series Funds 43992 $0.02 %0.00 %as of Mar 31, 2026 ↗
ProShares Hedge Replication ETF ProShares Trust 30689.1 $0.00 %0.00 %as of Feb 28, 2026 ↗
Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I 26599.8 $0.02 %0.00 %as of Mar 31, 2026 ↗
ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust 10229.7 $0.02 %0.00 %as of Feb 28, 2026 ↗
Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust 8184.6 $0.01 %0.00 %as of Mar 31, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Virtus Biotech Clinical Trials Etf ETFis Series Trust I 0.94 %as of Apr 30, 2026 ↗
Select Biotechnology Portfolio Fidelity Select Portfolios 0.72 %as of Feb 28, 2026 ↗
ALPS Medical Breakthroughs ETF ALPS ETF TRUST 0.61 %as of Feb 28, 2026 ↗
Tema Oncology ETF Tema ETF Trust 0.59 %as of Feb 28, 2026 ↗
Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust 0.48 %as of Apr 30, 2026 ↗
Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund Goldman Sachs Variable Insurance Trust 0.27 %as of Mar 31, 2026 ↗
Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust 0.27 %as of Apr 30, 2026 ↗
Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust 0.24 %as of Apr 30, 2026 ↗
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST 0.22 %as of Mar 31, 2026 ↗
PROFUND VP BIOTECHNOLOGY ProFunds 0.21 %as of Mar 31, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q2138+148,420,250+4.6 %
2026Q1124+118,048,999+2.0 %
2025Q4113+47,892,971+33.9 %
2025Q3109-55,895,447-5.2 %
2025Q2114+116,219,152+0.6 %
2025Q1103+76,180,810+16.7 %
2024Q496+185,297,585+55.8 %
2024Q378+173,400,143+6.8 %
2024Q261+593,183,900+212,160.0 %
2024Q121,500

Institutional managers

131 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
SUVRETTA CAPITAL MANAGEMENT, LLC4,401,083101.5M $as of Mar 31, 2026
INFINITUM ASSET MANAGEMENT, LLC4,148,92395.7M $as of Mar 31, 2026
HHLR ADVISORS, LTD.3,929,11790.6M $as of Mar 31, 2026
ORBIMED ADVISORS LLC3,027,32869.8M $as of Mar 31, 2026
FMR LLC3,016,13269.6M $as of Mar 31, 2026
BlackRock, Inc.2,530,30158.4M $as of Mar 31, 2026
Octagon Capital Advisors LP1,971,05445.5M $as of Mar 31, 2026
NOVO HOLDINGS A/S1,942,14244.8M $as of Mar 31, 2026
Sofinnova Investments, Inc.1,696,75239.1M $as of Mar 31, 2026
General Catalyst Group Management, LLC1,494,78634.5M $as of Mar 31, 2026
STATE STREET CORP1,421,41532.8M $as of Mar 31, 2026
Vivo Capital, LLC885,91620.4M $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC853,42719.7M $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC803,65218.5M $as of Mar 31, 2026
Point72 Asset Management, L.P.748,19517.3M $as of Mar 31, 2026
HSG Holding Ltd663,30814M $as of Mar 31, 2026
Fund 1 Investments, LLC499,99011.5M $as of Mar 31, 2026
UBS Group AG486,26311.2M $as of Mar 31, 2026
Balyasny Asset Management L.P.426,2819.8M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC425,9239.8M $as of Mar 31, 2026
D. E. Shaw & Co., Inc.368,7958.5M $as of Mar 31, 2026
Logos Global Management LP350,0008.1M $as of Mar 31, 2026
NORTHERN TRUST CORP268,8126.2M $as of Mar 31, 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC258,7726M $as of Mar 31, 2026
NOMURA HOLDINGS INC242,0505.6M $as of Mar 31, 2026

Declared shareholders of ArriVent Biopharma Inc

There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
FMR LLC and 1 other6.80 %3,016,132as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Funds holding ArriVent Biopharma Inc". https://titelia.com/en/stocks/arrivent-biopharma-inc-US04272N1028